Skip to main content
Clinical Trials/JPRN-UMIN000005712
JPRN-UMIN000005712
Completed
Phase 2

Prevention of the chemotherapy-induced oral mucositis by the rebamipide in breast cancer patients (Phase II) - Prevention of the chemotherapy-induced oral mucositis by the rebamipide in breast cancer patients -Cinderella Study BC2011

Cinderella Study Group0 sites160 target enrollmentAugust 1, 2011
ConditionsOral mucositis

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Oral mucositis
Sponsor
Cinderella Study Group
Enrollment
160
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 1, 2011
End Date
June 1, 2013
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Cinderella Study Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patient with impossible oral ingestion of medicine 2\)Patients with allergy history for rebamipide 3\)Patient with breast cancer relapse or metastasis 4\)Women during pregnancy, and women who has likelihood of pregnancy or the intention or breast\-feeding 5\)Patient who judged that doctor is improper excluding the above\-mentioned

Outcomes

Primary Outcomes

Not specified

Similar Trials